J.A. Aguirre

Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease

Giuseppa Mudò, Johanna Mäkelä, Valentina Di Liberto et al. · Cellular and Molecular Life Sciences · 2011 · 295 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Transgenic Expression +10

On the role of P2X7 receptors in dopamine nerve cell degeneration in a rat model of Parkinson’s disease: studies with the P2X7 receptor antagonist A-438079

Daniel Marcellino, Diana Suárez‐Boomgaard, María Dolores Sánchez-Reina et al. · Journal of Neural Transmission · 2010 · 97 citations

Molecular Pharmacology, Neurodegenerative Diseases, Medicine +10

Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP

J.A. Aguirre, Ján Kehr, Takashi Yoshitake et al. · Brain Research · 2005 · 55 citations · Full text

Neurophysiology, Medicine, Neurotransmitter +10

c-Fos expression in supramammillary and medial mammillary nuclei following spatial reference and working memory tasks

J.A. Aguirre, Sandra Rubio, Azucena Begega et al. · Physiology & Behavior · 2003 · 52 citations

Memory Tasks, Neuroanatomy, Medicine +7

Calcium movements during the release of catecholamines from the adrenal medulla: effects of methoxyverapamil and external cations

J.A. Aguirre, J. E. B. Pinto, J.M. Trifaró · The Journal of Physiology · 1977 · 49 citations

Electrolyte Disorder, Perfusion Fluid, Social Sciences +21